Alessandro Inno

26PUBLICATIONS
148CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 28, 2026
Integrating Nutrition and Exercise to Mitigate Cardiometabolic Risk and Enhance Outcomes in Lung Cancer During the Era of Immunotherapy and Targeted Therapy.

|Jun 15, 2026
Long-term outcomes of ALK inhibitors in metastatic ALK-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data.

|Feb 27, 2026
PIK3CA Alterations in NSCLC: Clinical Characteristics of a "Neglected" Population of Oncogene-Addicted Patients.

Sabrina Rossi, Arianna Pagliaro, Silvia Masini

|Feb 13, 2026
Chemoimmunotherapy Combinations in Elderly Patients with Metastatic Non-Small Cell Lung Cancer and PD-L1 Expression < 50%: Results from an Italian Real-World Study.

Antonello Veccia, Ettore D'Argento, Floriana Morgillo

|Nov 13, 2025
A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung Cancer.

Luigi Tarantini, Giuseppina Gallucci, Alessandro Inno

|Sep 27, 2025
Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore.

Andrea Camerini, Alessandro Inno, Maria Laura Canale

Pageof 5

Frequent Collaborators

8 joint publications

Stefania Gori

6 joint publications

Massimiliano Berretta

6 joint publications

Luigi Tarantini

6 joint publications

Irma Bisceglia